索菲亚基因的高管出于税收原因而卖掉了股票, SOPHiA GENETICS executives sold shares for tax reasons amid a quarterly loss and mixed analyst ratings.

瑞士数据公司SOPHiA GENETICS的几位高管上周在预先安排计划下出售股票, 以支付税务义务. Several executives at Swiss data company SOPHiA GENETICS sold shares last week under prearranged plans to cover tax obligations. 公司的季度亏损低于分析师预期, 市值约为3.34亿美元. The company reported a quarterly loss below analyst estimates and has a market cap of roughly $334 million. 分析师对此有不同的看法,两项"买入"和一项"卖出"建议,导致共识的"持仓"评级和7.00美元的目标价格. Analysts have a mixed outlook with two "Buy" and one "Sell" recommendation, resulting in a consensus "Hold" rating and a $7.00 price target.